Related Experiment Video
Updated: Jan 28, 2026

06:48
Emergency Undocking in Robotic Surgery: A Simulation Curriculum
Published on: May 20, 2018
10.1K
Pediatric Toxidrome Simulation Curriculum: Liquid Nicotine Overdose
Arvin Radfar Akhavan1, Rebekah Burns2, Kimberly Stone3
1Emergency Medicine Resident, University of Washington School of Medicine.
Mededportal : the Journal of Teaching and Learning Resources
|February 26, 2019
Summary
Acute liquid nicotine exposure in children is a growing concern. This simulation training improved healthcare providers
Area of Science:
- Pediatric Toxicology
- Medical Simulation
- Emergency Medicine Education
Background:
- Liquid nicotine exposure poses a significant risk to children due to high commercial concentrations.
- Pediatric liquid nicotine toxicity can manifest as altered mental status, seizures, and death.
Purpose of the Study:
- To develop and evaluate a simulation-based curriculum for managing acute liquid nicotine exposure in pediatric patients.
- To enhance healthcare providers' skills in identifying and treating pediatric nicotine toxicity.
Main Methods:
- A simulation-based case study was designed for pediatric emergency medicine fellows and residents.
- The curriculum focused on the approach to acutely ill pediatric patients with toxic exposures, emphasizing ABCs and seizure management.
- Didactic and preparatory materials were provided to instructors and learners.
Main Results:
- The simulation training received overwhelmingly positive feedback from participants.
- Participants reported increased confidence in evaluating and managing nicotine toxicity post-training (mean Likert score 4.9/5).
Conclusions:
- Simulation-based education is effective in improving provider confidence and skills in managing pediatric liquid nicotine exposure.
- This resource aids continuing education for providers on pediatric nicotine toxicity.
Related Concept Videos
Cholinergic Receptors: Nicotinic
5.6K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.6K
CNS Depressants: Alcohol and Nicotine
1.2K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism
213
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
272
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272

